WHO ICTRP trial
Safety and Efficacy Study of BP-DPC18 for the treatment of Femoropopliteal…
JPRN-jRCT2072200103 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCT2072200103 |
|---|---|
| Public title | Safety and Efficacy Study of BP-DPC18 for the treatment of Femoropopliteal Artery Lesions in Japan |
| Scientific title | SOL JAPAN Clinical Trial: Safety and Efficacy Study of BP-DPC18 for the treatment of Femoropopliteal Artery Lesions in Japan - SOL JAPAN |
| Primary sponsor | Soga Yoshimitsu |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Conditions | atherosclerotic disease |
| Interventions | Catheter for balloon dilatation angioplasty The investigational device has a drug coating containing Paclitaxel on the balloon surface. When inflating the balloon, the blood vessel will be mechanically expanded and Paclitaxel contained in… |
| Registration date | Jan 3, 2021 |
| Target size | 120 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: